September 12, 2008 – Navilyst Medical launched two new devices this week, an enhanced PICC Convenience Kitting and a new Xcela Power Injectable Port catheter provide a means for long-term delivery of fluids and medications including chemotherapy, and a new EZ Huber Safety Infusion Set offers a dual-action safety mechanism designed to reduce the risk of bloodborne pathogen exposure.

The new products will be premiered at Booth 202 at the upcoming Annual Scientific Meeting of the Association for Vascular Access (AVA) in Savannah, GA this week.

The products provide clinicians and hospitals the catheter and accessory choices they require for a procedure that is efficient and conducive to reducing the risk of accidental needlesticks (OSHA) and infections (CDC and Joint Commission). This also reduces costs from unnecessary supplies, the company said.

The company expanded its customized PICC Convenience Kit to include the new Xcela Power Injectable PICC and a wider array of PICC insertion accessories and packaging. The titanium Xcela ports, available in standard and low profile sizes, offer durability and reduced size for ease of implantation and patient comfort, the company claims. The plastic Xcela ports are lightweight for patient comfort and offer radiolucence-reduced imaging artifact. The plastic/titanium hybrid port design option combines the durability of titanium with the lightweight and radiolucence of plastic. All designs have a 5mL/sec with 300 psi infusion rating for use in contrast imaging procedures

Navilyst Medical’s new EZ Huber Safety Infusion Set offers a dual-action safety mechanism designed to reduce the risk of bloodborne pathogen exposure that threatens clinician safety and is a significant cost to the healthcare system. One safety feature shields the tip of the needle after the needle is withdrawn from the patient to prevent accidental needle sticks. The second safety feature is a protective cover that surrounds the entire needle after withdrawal to reduce exposure to aerosolized or splattered infusion fluids and blood.
The EZ Huber Safety Infusion Set is compatible with Navilyst Medical’s new Xcela Power Injectable Port and is rated for up to 5mL/sec at 300 psi for contrast-enhanced CT imaging procedures.

For more information: www.navilystmedical.com/press/


Related Content

News | Magnetic Resonance Imaging (MRI)

March 4, 2026 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Bayer for the expanded ...

Time March 04, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Ultrasound Imaging

March 2, 2026 — Esaote Group will officially launch the new MyLab E85 and MyLab C30 GTS Edition ultrasound systems at ...

Time March 02, 2026
arrow
News | Remote Viewing Systems

Feb. 26, 2026 — DeepHealth, Inc., a provider of AI-powered health informatics and a wholly owned subsidiary of RadNet ...

Time February 27, 2026
arrow
News | Interventional Radiology

Feb.12, 2026 — The University of South Florida’s Center for Advanced Medical Learning and Simulation (CAMLS), part of ...

Time February 23, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 9, 2026 — MRIguidance, a MedTech company developing BoneMRI, a radiation-free bone imaging solution, has appointed ...

Time February 09, 2026
arrow
Feature | Cardiac Imaging | Kyle Hardner

Advances in coronary CT angiography (CCTA) have reached the point where image quality and AI capabilities are creating ...

Time February 06, 2026
arrow
News | Artificial Intelligence

Dec. 1, 2025 — Researchers at the University of California, Berkeley and University of California, San Francisco have ...

Time December 10, 2025
arrow
News | FDA

Nov. 26, 2025 — a2z Radiology AI has received U.S. FDA clearance for a2z-Unified-Triage, a single device that flags and ...

Time December 03, 2025
arrow
News | FDA

Nov. 25, 2025 —Bracco Diagnostics Inc. has announced that the U.S. Food and Drug Administration (FDA) has expanded the ...

Time November 26, 2025
arrow
Subscribe Now